Search for Clinical Trial Results
Idiopathic Thrombocytopenic Purpura - 26 Studies Found
Status | Study |
Completed |
Study Name: Clinical Trial of Rituximab in Children and Adolescents With Chronic Idiopathic Thrombocytopenic Purpura (ITP) Condition:
|
Completed |
Study Name: Interventional Study in Adults With Immune Thrombocytopenia Purpura (ITP) Receiving Romiplostim Condition: Idiopathic Thrombocytopenic Purpura Date: 2010-06-10 Interventions: Biological: Romiplostim Romiplostim will be administered weekly by subcutaneous injection |
Recruiting |
Study Name: Long-term Safety Study of Treatment With the Thrombopoietin Agonists Eltrombopag and Romiplostim in Patients With Immune Thrombocytopenia (ITP) Condition: Idiopathic Thrombocytopenic Purpura Date: 2011-09-13 |
Completed |
Study Name: Phase 2, Parallel Group, Rollover Study of AKR-501 in Patients With ChronicITP Who Completed 28 Days of Study Treatment in Protocol 501-CL-003 Condition: Idiopathic Thrombocytopenic Purpura Date: 2008-02-19 Interventions:
|
Completed |
Study Name: Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Condition:
|
RECRUITING |
Study Name: Comparative Study of Clinical Efficacy and Safety of GNR-069 and Nplate in Patients With ITP Condition: Idiopathic Thrombocytopenic Purpura Date: 2024-05-19 Interventions: Once a week as a subcutaneous injection.The initial dose is 1 mcg/kg. |